New Series of VEGFR-2 Inhibitors and Apoptosis Enhancers: Design, Synthesis and Biological Evaluation

BACKGROUND: Cancer is still a major world health threat, causing a high rate of mortality. VEGFR-2 inhibitor anticancer agents are of great significance. However, they showed some serious side effects. PURPOSE: To discover new effective and safer anticancer agents, a new series of piperazinylquinoxa...

Descripción completa

Detalles Bibliográficos
Autores principales: Abdallah, Abdallah E, Mabrouk, Reda R, Elnagar, Mohamed R, Farrag, Amel Mostafa, Kalaba, Mohamed H, Sharaf, Mohamed H, El-Fakharany, Esmail M, Bakhotmah, Dina Abed, Elkaeed, Eslam B, Al Ward, Maged Mohammed Saleh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8904266/
https://www.ncbi.nlm.nih.gov/pubmed/35281317
http://dx.doi.org/10.2147/DDDT.S344750

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8904266/
https://www.ncbi.nlm.nih.gov/pubmed/35281317
http://dx.doi.org/10.2147/DDDT.S344750

Ejemplares similares